Your browser doesn't support javascript.
loading
Erdheim-Chester Disease With Multiorgan Involvement, Following Polycythemia Vera: A Case Report.
Iurlo, Alessandra; Dagna, Lorenzo; Cattaneo, Daniele; Orofino, Nicola; Bianchi, Paola; Cavalli, Giulio; Doglioni, Claudio; Gianelli, Umberto; Cortelezzi, Agostino.
Affiliation
  • Iurlo A; From the Oncohematology Division, IRCCS Ca' Granda - Maggiore Policlinico Hospital Foundation, and University of Milan (AI, DC, NO, PB, AC); Oncohematology Unit of the Elderly, IRCCS Ca' Granda - Maggiore Policlinico Hospital Foundation (AI); Unit of Medicine and Clinical Immunology, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University (LD, GC); Unit of Pathology, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University (CD); and Hematopathology Servic
Medicine (Baltimore) ; 95(20): e3697, 2016 May.
Article in En | MEDLINE | ID: mdl-27196481
Erdheim-Chester disease is a rare form of non-Langerhans cell histiocytosis characterized by the migration and infiltration of lipid-laden CD68, CD1a and S100 histiocytes to various target organs, which leads to the disruption of physiological tissue architecture and reactive fibrosis, and thus impairs organ function.We describe the first case of a patient with Erdheim-Chester disease with multiorgan involvement developed after 6 years from polycythemia vera diagnosis. During the follow-up, an abdominal ultrasound scan revealed the presence of dense, bilateral perinephric infiltration. A computed tomographic guided core biopsy was performed in order to identify the histological nature of this lesion, and a morphological analysis demonstrated the accumulation of foamy histiocytes surrounded by fibrosis. The BRAFV600E mutation was detected, and a diagnosis of Erdheim-Chester disease was made.The extreme rarity of Erdheim-Chester disease strongly suggests the existence of potentially common element(s) that may have contributed to the pathogenesis of both disorders. Obviously, further studies are needed to clarify the mutual roles and effects of JAK2 and BRAF mutations in this patient, as well as their possible therapeutic implications.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polycythemia Vera / Bone Marrow / Erdheim-Chester Disease Type of study: Diagnostic_studies / Etiology_studies / Prognostic_studies Limits: Aged / Humans / Male Language: En Journal: Medicine (Baltimore) Year: 2016 Document type: Article Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polycythemia Vera / Bone Marrow / Erdheim-Chester Disease Type of study: Diagnostic_studies / Etiology_studies / Prognostic_studies Limits: Aged / Humans / Male Language: En Journal: Medicine (Baltimore) Year: 2016 Document type: Article Country of publication: United States